The Science of MS Management: Assessing Safety and Potential Risks of Disease Modifying Therapies for Multiple Sclerosis
Date: - Time: -
Corey C. Ford, MD, PhD; Edward J. Fox, MD, PhD
Upon completion of this educational activity, the participant should be able to:
•Review available safety and risk information applicable to current, new, and emerging disease-modifying therapy in MS; •Analyze the potential sources of safety concerns associated with disease-modifying therapies and utilize best practice guidelines for selecting and changing therapies ; •Educate patients about known safety risks and benefits of newer MS therapies and apply this information and other factors in therapeutic selection.
1.0 AMA PRA Category 1 Credits™